The critically important job of fighting off infections falls to our
immune system. As you might expect, this is a complex system; it must
be, because the invasions faced by the human body include diverse infectious
agents including bacteria, viruses, fungi, and so on, as well as attacks
from newly formed cancer cells. A large part of the immune system is located in or near the intestinal
tract and helps prevent microorganisms in the intestine from entering
into the rest of the body. Defects in the immune
system may therefore lead to overgrowth of the intestinal tract with organisms
like yeast.
The B-lymphocyte cells of the immune system produce antibodies called
immunoglobulins. These antibodies are designed to react against specific
antigens (or foreign molecules) introduced into the system by microorganisms
of various types. Antibodies react against microorganisms (viruses, yeast,
parasites, and bacteria) and allow them to be killed by the white blood
cells. Composed mostly of amino acids, antibodies are proteins and divided
into five major antibody classes (IgM, IgG, IgE, IgA, IgD). Each antibody
class has a unique chemical structure and a specific function. IgG stands
for immunoglobulin G or antibody G and so forth. Each class contains thousands
of different antibodies to different microorganisms, foods, and chemicals.
IgM
IgM is usually
the first antibody produced by the immune system when a new microorganism
is encountered and is the body’s early defense system. The presence
of high amounts of specific IgM antibodies indicates a recent infection.
Thus, high levels of IgM antibodies against Candida would indicate
a recent Candida infection. IgM antibodies diminish a few months after
infection.
IgG
IgG antibodies
are produced by the B-lymphocytes when the body is attacked by the
same microorganism in a subsequent invasion. It may also be involved
in causing food allergies. IgG antibodies
are the antibodies that provide long term resistance to infections
after immunizations.
IgG subclasses
Sometimes
the total IgG in the blood may be normal but the concentration of
one or more subtypes of IgG may be low. As a result, a normal
IgG level can be misleading if it is not accompanied by normal levels
of each subclass. There are four subtypes of IgG: IgG1, IgG2, IgG3,
and IgG4.
IgE
IgE is the
antibody most widely known for its involvement in allergies of all
kinds. It may also be involved in protection of the body from
parasites. Elevated IgE in blood is associated with a history of excessive
allergies.
IgA
IgA is the
antibody involved in protecting the nasal and intestinal lining from
microorganisms. Secretory IgA (sIgA) is a special form of the
IgA antibody that is secreted to protect the mucosa, which is the
lining of the intestinal tract. Secretory IgA is apparently secreted
by the gall bladder and then trickles down the bile ducts into the
small intestine.
Autism & PDD
Defects in all parts of the immune
system are documented in people with autism. Studies done by
Reed Warren Ph.D. at Utah State University, Sudhir Gupta MD Ph.D., a
clinical immunologist at the University of California at Irvine Medical
School, and others indicate most children with autism have a substantial
immune abnormality of some type. Reported defects include myeloperoxidase
deficiency, severe combined immunodeficiency, IgA deficiencies (partial
and complete), IgG subclass deficiencies in 20%, and deficiencies in
complement C4b. Poor digestive function has a number of causes. The reduced function may be the result of an immature gut in infancy and of heavy metals causing the chemical messages weaving through the body to trip the allergy system.
In Gupta’s study, 20% of the children with autism had
a deficiency of IgA and 8% lacked it completely. Reed Warren and his
colleagues also found that 20% of individuals with autism had low serum
IgA compared with none of the normal individuals used as controls.
Concentrations of IL-12 and interferon gamma are much
higher in the blood of children with autism than in normal children,
indicating an immune activation, possibly due to adverse vaccine reactions.
An optimal immune response to Candida infections necessitates a finely
tuned balance of interferon gamma production; the dysregulation of the
immune system, caused by IL-12-induced increases in gamma interferon,
leads to increased Candida susceptibility in animals.
Down Syndrome
The overexpression of genes resulting
from trisomy 21 in Down Syndrome may be responsible for many of the
abnormalities of the immune system reported in Down Syndrome. The level of superoxide disimutase-1, which is coded by a gene on chromosome
21, is on average, 150% of the values found in normal individuals’ blood
as well as other cells. The high enzyme activity results in a high rate
of conversion of superoxides to peroxides, resulting in high levels
of peroxides that may damage DNA and lipids, and in low levels of the
superoxides that are essential for killing microorganisms such as Staphylococcus
aureus and Candida albicans.
Over expression of lymphocyte function associated antigen-1(LFA-1),
which is also coded on chromosome 21, may lead to an abnormal interaction
between cells from the thymus, resulting in aberrant T-cell maturation
and selection. Overexpression of the interferon receptor gene also located
on chromosome 21 is common in Down Syndrome and may also contribute
to immune deficiency. Low serum zinc common in Down Syndrome, may
also cause weak immunity.
The most significant abnormality
of the immune system in Down Syndrome is a 30-fold increase in the
incidence of acute leukemia and a 200-fold increase in acute megakaryocytic
leukemia. 30% of adults with Down Syndrome are deficient in
IgG-2 and/or IgG-4 and these deficiencies are also common in children
with Down’s syndrome. Elevations of IgG-1 and IgG-3 are common in persons
with Down Syndrome. In children with the abnormal immunoglobulin pattern,
selenium supplementation at a dose of 10 mcg/kg (4.54 mcg/lb.) body
weight for six months significantly increased IgG-2 and IgG-4 levels
and reduced the number of infections.
Seizure Disorders & Epilepsy
Intractable childhood epilepsy
is associated with low blood values of IgG-2 and IgG-4; replacement
therapy may lead to remission of symptoms. IgG-4 may also be
low in some children with febrile convulsions. The antiseizure drug
carbamazepine (Tegretol) may cause a reduction in IgG-2 while phenytoin
(Dilantin) may be associated with decreases in IgA, IgG-3, and IgG-4.
Anti-IgA antibodies have been detected in epileptic patients with low
serum IgA concentrations.
Ataxia Telangiectasia (AT)
Ataxia telangiectasia is a genetic disorder characterized
by ataxia or impaired balance between the age of two and five years
and worsens as the child gets older. There is usually a cortical cerebellar
degeneration of the brain, involving mainly the Purkinje and granule
cells; degeneration of these same cells in the cerebellum has also been
detected in autopsy studies of individuals with autism. Affected children
also have telangiectases, "spider" veins appearing in the corners of
the eyes or on the surface of the ears and cheeks that are exposed to
sunlight.
Telangiectases often do not appear until the age of six,
and sometimes much older. Similarly, a history of recurrent sinopulmonary
infections would heighten suspicion of AT. Many affected children with
this disorder also have low serum IgA, IgG, IgG-2, IgG-4 and/or IgE.
In 16 patients with ataxia-telangiectasia, eight had IgA deficiency,
two had IgG and IgA deficiency and six patients showed no immunoglobulin
class abnormality. IgG-4 and IgG-2 levels were undetectable or low in
almost every patient in this group. An IgG-3 deficiency was associated
with the IgG-2 and IgG-4 defect in three patients with undetectable
IgA. IgG-1 was very low in one patient with a total IgG deficiency.
Children with AT are 1000 times
as likely to develop cancer than other children. Gamma globulin treatment
may be helpful for treatment of the impaired immunity in this disorder.
The most consistent laboratory marker of AT is an elevated serum alpha-fetoprotein
after the age of two years. At least one percent of the general population
are "AT carriers". This would mean that at least two million people
in the United States alone carry one copy of the defective AT gene and
one copy of a good one. It appears that carriers of this gene are much
more susceptible to radiation effects and are more likely to develop
cancer.
Gastrointestinal Disorders,
Including Celiac Disease
Because the gastrointestinal tract is the largest lymphoid
organ in the body, it is not surprising that patients with immunodeficiency
present with pathological conditions in the intestine. Several
studies have documented a high prevalence of inflammatory, malignant,
and infectious gastrointestinal (GI) disorders in patients with common
variable immunodeficiency or immunoglobulin A (IgA) deficiency.
For example, celiac disease, an inflammation of the bowel, is commonly
associated with IgA deficiency. The incidence of selective IgA deficiency
is 10 times higher in patients with celiac disease compared to the general
population. The diagnosis of celiac disease cannot be excluded if a
person is IgA deficient, because the endomysial antibody test uses an
IgA antibody specificity and may yield false negative results in such
cases. Thus, it would seem wise to always test for IgA deficiency whenever
the IgA endomysial antibody test for celiac disease is done.
Hyper IgE Syndrome
The hyper-IgE (HIE) syndrome is characterized by high
IgE serum levels, chronic dermatitis, and recurrent infections. Hyper
IgE syndrome is due to an overproduction of IgE probably due to a terminally
differentiated B cell population, no longer sensitive to regulatory
signals. Common clinical findings are recurrent
sinopulmonary tract infections, cold staphylococcal abscesses and chronic
dermatitis. Many patients have serum IgE levels of 3,000 U/ml
and blood eosinophilia (0.6 x 109 cells/l). Some patients have impaired
antibody forming capacity to tetanus and pneumococcal antigens and low
serum IgG-2 levels.
After initiation of the intravenous gamma globulin therapy,
an improvement of infectious problems was observed in some studies.
Serum IgE levels were highly correlative with serum IgG-4 levels (r
= 0.75) in one study but do not correlate significantly with other IgG
subclasses. The cytokine recombinant IL-4 enhanced not only spontaneous
IgE synthesis but also IgG-4 synthesis in cultures of lymphocytes from
patients with HIE syndrome as well as in healthy donors (P less than
0.01).
The effect of recombinant IL-4 on both IgE and IgG-4 synthesis
was inhibited by low concentrations of recombinant IFN-gamma (p less
than 0.01). The disturbed regulation of IgE and IgG-4 seen in patients
with hyper IgE syndrome may be caused mainly by the disturbed regulation
of both cytokines.
A child with joint deformities involving both hands, frequent
fractures, chronic eczema and recurrent skin and soft tissue infections
since infancy, was found to have a pneumatocele during admission. Immunologic
abnormalities included extremely elevated serum IgE levels (18989 U/ml)
and lack of immune response (anergy) to Candida, purified protein derivative,
and tetanus toxoid. A high index of suspicion for HIE syndrome should
be generated in patients with recurrent skin infections and orthopedic
complaints.
Abnormal IgE in Allergies &
Other Conditions
Elevated values for IgE are found
in allergic disorders including asthma, hayfever, parasitic infestations,
deficiencies of the thymus gland, Wiskitt Aldrich syndrome, IgE myeloma,
pemphigoid, periarteritis nodosa, and hypereosinophilic syndrome. Low values for IgE are found in ataxia telangiectasis and in various
hypogammaglobulinemias.
If the total IgE exceeds 75-100 U/ml, a patient is likely
to have significant IgE-mediated allergies that should be tested
by specific IgE and other allergy tests. If the IgE is less than
10 U/ml, the patient is unlikely to have significant IgE-mediated allergies.
Patients with intermediate values for total IgE will generally have
intermediate numbers of IgE-mediated allergies.
Importance of Zinc to the Immune System
Zinc is an essential element that is commonly deficient
in individuals who eat a diet high in cereal content but low in animal
protein. Cereals contain phytic acid which binds zinc and inhibits its
absorption from the intestinal tract.
Clinical signs of zinc deficiency may occur when plasma
zinc concentrations drop below 65 mcg/dL. Zinc
deficiency is associated with dermatitis, poor wound healing, retarded
growth and sexual development, and reduced taste acuity. Values less
than 33 mcg/dL are particularly associated with loss of the senses of
taste and smell, abdominal pain, diarrhea, skin rash, and loss of appetite.
Zinc deficiency may be
common in children with autism who may have had diarrhea for extended
time periods and may contribute to their poor appetites. Zinc affects
multiple aspects of the immune system, from the barrier of the skin
to gene regulation within lymphocytes.
Zinc is also crucial for the normal function of cells
which mediate nonspecific immunity, such as neutrophils and natural
killer cell. B lymphocyte development and antibody production, particularly
immunoglobulin G, is compromised by zinc deficiency. The macrophage,
a pivotal cell in many immunologic functions, is adversely affected
by zinc deficiency. This can dysregulate intracellular killing, cytokine
production, and phagocytosis.
The effects of zinc on these key immunologic mediators
is rooted in the myriad roles for zinc in basic cellular functions such
as DNA replication, RNA transcription, cell division, and cell activation.
Apoptosis or programmed cell death is potentiated by zinc deficiency.
Zinc also functions as an antioxidant and can stabilize membranes.
Zinc Deficiency & Crohn’s Disease
Low serum zinc in Crohn's disease
may cause clinical manifestations, such as acrodermatitis enteropathica
and retinal dysfunction, which may be correctable with zinc supplementation.
Zinc Treatment of Candidiasis
Polizzi and coworkers evaluated the clinical efficacy
of a treatment with cimetidine and zinc sulfate in an adult patient
with chronic mucocutaneous candidiasis. Cimetidine was given at a dose
of 400 mg three times daily; zinc sulfate at a dose of 200 mg daily,
then adjusted to maintain blood zinc levels at the upper normal range.
This treatment lasted 16 months. An impressive and significant reduction
of the infectious events and an increased CD4 (helper/inducer) cell
counts were observed. The authors conclude that
this combined immunopotentiating treatment is safe and inexpensive to
treat immunodeficiency disorders.
Zinc Reduction of Infectious Diseases
The August 1998 issue of the American Journal of Clinical
Nutrition is devoted to studies on zinc and health. Anuraj Shankar,
an immunologist at the Johns Hopkins School of Public Health, working
with other experts in a child health study, found the trace mineral
can have remarkable effects.
They found that adding small amounts
of zinc to the diet could reduce the duration of a diarrhea attack by
20 to 30 percent and could stop up to 38 percent of cases from ever
happening.
"The incredible thing about zinc is that if you look at
the three major killers of children everywhere -- diarrhea, malaria
and pneumonia -- we are seeing that zinc has a very significant impact
on reducing the severity and incidence of those," said Shankar.
Zinc supplementation reduced acute
respiratory infections such as pneumonia by up to 45 percent and malaria
by 35 percent, Shankar said in a telephone interview. One study
in India found that children with low blood levels of zinc had more
bouts of diarrhea, and were more likely to have fever along with diarrhea.
A study in Vietnam found a 2.5-fold decrease in all respiratory infections
when children received zinc supplements.
Hyperactivity, Zinc Deficiency,
& Food Dyes
Children with hyperactivity had
significantly lower hair, blood, fingernail, and urine zinc compared
to age and sex-matched controls. The yellow food dye tartrazine
may bind to zinc in the blood as a chelating agent and thereby reduce
blood zinc. Hyperactive children exposed to this food dye all developed
significant negative symptoms within 45 minutes of ingesting this food
dye in a colored drink.
Zinc Deficiency & Anorexia Nervosa
A number of studies have indicated
that a high percentage of females with anorexia nervosa may have low
serum zinc values, may choose diets with inadequate zinc content,
and may respond favorably to zinc supplementation by increased weight
gain and reduced depression and anxiety.
Send this page to a friend
References
Autism
Warren R, Odell J, Warren W, Burger R, Maciulis A, Daniels W,
Torres A. "Immunoglobulin A deficiency in a subset of autistic
subjects. "J. Autism Develop Dis. 27:187-192,1997.
Warren R, Margaretten N, Pace N, Foster A: "Immune abnormalities
in patients with autism." J. Autism Develop Dis. 16, 189-197,
1986.
Warren R, Singh V, Cole P, Odell J, Pingree C, Warren L, DeWitt
C, McCullough M: "Possible association of the extended MHC haplotype
B44-SC30-DR4 with autism."Immunogenetics 36: 203-207, 1992.
Warren R, Yonk J, Burger R, Odell J, Warren W: "DR positive
T cells in autism: association with decreased plasma levels of the
complement C4B protein." Neuropsychobiology 31: 53-57, 1995.
Singh V, Warren RP, Odell JD, and Cole P: "Changes in soluble
interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-I
in the serum of autistic children." Clin. Immunol. Immunopath.
61: 448-455, 1991.
Yonk L J, Warren R P, Burger R A, Cole P, Odell J D, Warren W L,
White E, Singh VK: "CD4+ helper T cell depression in autism."
Immunol Lett 25: 341-346, 1990.
Abramason RK, Self S, Genco P, Smith N, Pendleton A, Valentine
J, Wright H H, Cuccaro M, Powell D: "The relationship between
lymphocyte cell surface markers and serotonin in autistic probands
(abstract)." Am J Hum Genet 47(3):A45, 1990.
Wood Frei B, Dennv D, Gaffney G R, O'Donne U: "T-Lymphocyte
subsets and the interleukin-2 system in autistic children (abstract)."
Sci Proc Annu Meet Am Acad Child Adolesc Psychiatry 7: 53, 1991.
Plioplys A V, Greaves A, Kazemi K, Silverman E. "Lymphocyte
function in autism and Rett syndrome." Neuropsychobiology 7:
12-16, 1994.
Stubbs E G, Crawford M L, Burger D R, Vanderbark A A: "Depressed
lymphocyte responsiveness in autistic children." J Autism Child
Schizophr 7:49-55, 1977.
Warren R, Yonk L, Burger R, Cole P, Odell J, Warren W, White E,
Singh V: "Deficiency of suppressor-inducer (CD4+CD45R+) T cells
in autism." Immunol Invest 19:245-251,1990.
Singh V K, Fudenberg H H, Emerson D, Coleman M: "Immunodiagnosis
and immunotherapy in autistic children." Ann NY Acad Sci 540:602-604,
1988.
Ferrari P, Marescot M, Moulias R, Bursztejn C, Deville-Chambrolle
A, Thiolett M, Lesourd B, Braconnier A, Dr.eux C, Zarifian E. "Immune
status in infantile autism: Correlation between the immune status,
autistic symptoms and levels of serotonin." Encephale 14: 339-344,
1988.
Warren R P, Foster A, Margaretten N C: "Reduced natural killer
cell activity in autism."J Am Acad Child Psychol 26: 333-335,
1987.
Warren P P, Singh V K, Cole P, Odell J D, Pingree C B, Warren W
L, White E: "Increased frequency of the null allele at the complement
C4B locus in autism." Clin Exp Immunol 83: 438-440, 1991.
Weizman A, Weizman R, Szekely G A, Wijsenbeek H, Livini E: "Abnormal
immune response to brain tissue antigen in the syndrome of autism."
Am J Psychiatry 139:1462-1465,1982.
Singh V K, Warren R P, Odell J D, Warren W L, Cole P: "Antibodies
to myelin basic protein in children with autistic behavior."
Brain Behav Immunity 7: 97-103, 1993.
Plioplys A V, Greaves A, Kazemi K, Silverman E. "Immunoglobulin
reactivity in autism and Rett's syndrome." Dev Brain Dysfunct
7: 12-16, 1994.
Todd R, Ciaranello R. "Demonstration of inter- and intraspecies
differences in serotonin binding sites by antibodies from an autistic
child." Proc Nat Acad Sci 82:612-616, 1985.
Gupta S, Aggarwal, Heads C: "Dysregulated immune system in
children with autism. Beneficial effects of intravenous immune globulin
on autistic characteristics." Autism Develop Dis 26:439-452,
1996.
Kontstantareas M, Homatidis S: "Ear infections in autistic
and normal children." J Autism and Dev Dis 17:585,1987.
Down Syndrome
Nishida Y, Sano Y, Akaoka I, Maruki M, Suzuki T, Maruki K: "Abnormal
serum immunoglobulin levels in Down's syndrome patients." Am
J Ment Defic 1978 Jul;83(1):16-20
Anneren G, Magnusson C G, Nordvall S L: "Increase in serum
concentrations of IgG2 and IgG4 by selenium supplementation in children
with Down's syndrome." Arch Dis Child 1990 Dec;65(12):1353-5
Sustrova M, Strbak V: "Thyroid function and plasma immunoglobulins
in subjects with Down's syndrome (DS) during ontogenesis and zinc
therapy." J Endocrinol Invest 1994 Jun; 17(6):385-90
Lockitch G, Puterman M, Godolphin W, Sheps S, Tingle A J, Quigley
G: "Infection and immunity in Down syndrome: a trial of long-term
low oral doses of zinc." J Pediatrics 1975; 86:207-211.
Mehta P D, Dalton A J, Mehta S P, Percy M E, Sersen E A, Wisniewski
H M: "Immunoglobulin G subclasses in older persons with Down
syndrome." J Neurol Sci 1993 Jul; 117(1-2):186-91
Anneren G, Magnusson C G, Lilja G, Nordvall S L: "Abnormal
serum IgG subclass pattern in children with Down's syndrome."
Arch Dis Child 1992 May; 67(5):628-31
Loh R K, Harth S C, Thong Y H, Ferrante: "A Immunoglobulin
G subclass deficiency and predisposition to infection in Down's syndrome."
Pediatr Infect Dis J 1990 Aug; 9(8):547-51.
Nishida Y, Sano Y, Akaoka I, Maruki M, Suzuki T, Maruki K: "Abnormal
serum immunoglobulin levels in Down's syndrome patients." Am
J Ment Defic 1978 Jul; 83(1):16-20
Lockitch G, Singh V K, Puterman M L, Godolphin W J, Sheps S, Tingle
A J, Wong F, Quigley G: "Age-related changes in humoral and cell-mediated
immunity in Down syndrome children living at home." Pediatr Res
1987 Nov; 22(5):536-40.
Reichelt KL, Lindback T, Scott H: "Increased levels of antibodies
to food proteins in Down syndrome." Acta Paediatr Jpn 1994 Oct;
36(5):489-92.
Seizures & Epilepsy
Lenti C, Masserini C, Barlocco A, Peruzzi C, Morabito A: "IgG2
deficiency in children with febrile convulsions: a familial study."
Ital J Neurol Sci 1993 Oct; 14(7):561-4
Bouma PA: "Determining the prognosis of childhood epilepsies
by establishing immune abnormalities." Clin Neurol Neurosurg
1992; 94 Suppl:S54-6
Fois A, Vascotto M, Di Bartolo R M, Di Marco V: "Celiac disease
and epilepsy in pediatric patients." Childs Nerv Syst 1994 Sep;
10(7):450-4
van Rijckevorsel-Harmant K, Delire M, Schmitz-Moorman W, Wieser
H G: "Treatment of refractory epilepsy with intravenous immunoglobulins.
Results of the first double-blind/dose finding clinical study."
Int J Clin Lab Res 1994; 24(3):162-6
Fois A, Vascotto M: "Use of intravenous immunoglobulins in
drug-resistant epilepsy." Childs Nerv Syst 1990 Nov;6(7):400-5
van Engelen BG, Renier W O, Weemaes C M, Strengers P F, Bernsen
P J, Notermans S L: "High-dose intravenous immunoglobulin treatment
in cryptogenic West and Lennox-Gastaut syndrome; an add-on study."
Eur J Pediatr 1994 Oct; 153(10):762-9
Hart Y M, Cortez M, Andermann F, Hwang P, Fish D R, Dulac O, Silver
K, Fejerman N, Cross H, Sherwin A, et al: "Medical treatment
of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect
of high-dose steroids or immunoglobulins in 19 patients." Neurology
1994 Jun; 44(6):1030-6
Gross-Tsur V, Shalev R S, Kazir E, Engelhard D, Amir N: "Intravenous
high-dose gamma globulins for intractable childhood epilepsy."
Acta Neurol Scand 1993 Sep; 88(3):204-9
Prasad A N, Stafstrom C F, Holmes G L: "Alternative epilepsy
therapies: the ketogenic diet, immunoglobulins, and steroids."
Epilepsia 1996;37 Suppl 1:S81-95.
Kumar S, Seymour G J, Lavin M F: "Immunoglobulin synthesis
and gene rearrangement in ataxia-telangiectasia B-lymphoblastoid cell
lines." Int Arch Allergy Appl Immunol 1989; 89(2-3):264-8
Datta U, Sehgal S, Kumar L, Kaur K J, Walia B N, Chopra J S, Marwaha
R K: "Immune status in ataxia telangiectasia." Indian J
Med Res 1991 Jun; 94:252-4.
Graham-Pole J, Ferguson A, Gibson A A, Stephenson J B: "Familial
dysequilibrium-diplegia with T-lymphocyte deficiency." Arch Dis
Child 1975 Dec; 50(12):927-32
Doi S, Saiki O, Hara T, Sugita T, Ha-Kawa K, Tanaka T, Hara H,
Negoro S, Yabuuchi H, Kishimoto S: "Administration of recombinant
IL-2 augments the level of serum IgM in an IL-2 deficient patient."
Eur J Pediatr 1989 Jun; 148(7):630-3.
Gastrointestinal Disorders
Lai Ping So A, Mayer L: "Gastrointestinal manifestations of
primary immunodeficiency disorders." Semin Gastrointest Dis 1997
Jan; 8(1):22-32.
Fois A, Vascotto M, Di Bartolo RM, Di Marco V: "Celiac disease
and epilepsy in pediatric patients." Childs Nerv Syst 1994 Sep;
10(7):450-4.
Thomas, H C and Jewell, D P: Gastrointestinal Immunology.
Oxford: Blackwell Scientific Publications. pg. 100-120, 1979.
Reichelt K, Ekrem J, Scott H: "Gluten, milk proteins and autism:
dietary intervention effects on behavior and peptide secretion."
Journal of Applied Nutrition 42: 1-11, 1990.
Zinc Deficiency & Infectious Diseases
Caulfield L E, Zavaleta N, Shankar A H, Merialdi M: "Potential
contribution of maternal zinc supplementation during pregnancy to
maternal and child survival." Am J Clin Nutr 1998 Aug; 68 (2
Suppl):499S-508S
Shankar A H, Prasad A S: "Zinc and immune function: the biological
basis of altered resistance to infection." Am J Clin Nutr 1998
Aug; 68(2 Suppl):447S-463S.
Myung S J, Yang S K, Jung H Y, Jung S A, Kang G H, Ha H K, Hong
W S, Min Y I: "Zinc deficiency manifested by dermatitis and visual
dysfunction in a patient with Crohn's disease." J Gastroenterol
1998 Dec; 33(6):876-9.
Polizzi B, Origgi L, Zuccaro G, Matti P, Scorza R: "Case report:
successful treatment with cimetidine and zinc sulphate in chronic
mucocutaneous Candidiasis." Amer J Med Sci 1996;311:189-190.
Della Bella S, Vanoli M, Bazzi S, Scorza R: "Successful treatment
of common variable immunodeficiency and related disorders with cimetidine
and zinc sulfate" Int J Clin Lab Res 1997; 27:79-80.
Diabetes
Van Thiel D H, Smith W I Jr, Rabin B S, Fisher S E, Lester R: "A
syndrome of immunoglobulin A deficiency, diabetes mellitus, malabsorption,
a common HLA haplotvpe. Immunologic and genetic studies of forty-three
family members." Ann Intern Med 1977 Jan;86(1):10-9.